# S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/s6r1-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/8b26bdc3-2353-4ffd-9979-02782ef51b85

> FDA guidance document: S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. Issue date: May 18, 2012. Get complete insights and analysis.

---

## Details

- Title: S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
- Communication Type: Guidance Document
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Issue Date: 2012-05-18
- Docket Number: FDA-2009-D-0573

## Related Documents

- [Antidepressant Drugs--Clinical Evaluation](https://www.keypedia.com/guidances/guidance-document/antidepressant-drugs-clinical-evaluation/917a8c68-33fb-4ab9-8cd8-0949cf5b2594)
- [Local Anesthetics--Clinical Evaluation](https://www.keypedia.com/guidances/guidance-document/local-anesthetics-clinical-evaluation/3b410fc1-fa8a-45a4-b6d8-fead0e7449dd)
- [Clinical Evaluation of General Anesthetics](https://www.keypedia.com/guidances/guidance-document/clinical-evaluation-of-general-anesthetics/3a1e22ac-c712-4b75-98b3-4ac4168ce81f)